Gastrointestinal Stents Market - By Product (Biliary Stent, Esophageal Stent, Colonic Stent, Pancreatic Stent, Duodenal Stent), By Application (Gastrointestinal Cancer, Biliary Disease, Colorectal Cancer, Stomach Cancer), By Material, By End-use, & Forecast, 2023 – 2032

Gastrointestinal Stents Market Size

Gastrointestinal Stents Market size was valued at around USD 465.2 million in 2022 and is projected to reach over USD 776.3 million by 2032. This incremental growth rate is owing to increasing prevalence of gastrointestinal cancer coupled with rising number minimally invasive surgeries globally.
 

Growing awareness regarding several advantages offered by technologically advanced gastrointestinal stents for a variety of GI procedures associated with ageing population is anticipated to drive the market progress. The gastrointestinal stents industry is witnessing a significant growth in the recent years owing to factors such as ageing population, technological advancements, enhanced patient outcome, among others.
 

Gastrointestinal disorders like colorectal cancer, esophageal strictures, and inflammatory bowel diseases (IBD) continue to affect a significant portion of the population, driving the demand for stent placement as a treatment option. Advances in medical technology have led to the development of sophisticated stent designs and materials, improving their effectiveness, safety, and compatibility with patients. Increasing awareness of gastrointestinal disorders and improved early detection methods have led to earlier intervention and a higher demand for stenting procedures. The gastrointestinal stents industry plays a vital role in providing therapeutic solutions for patients with various gastrointestinal disorders. Therefore, the gastrointestinal stents industry's growth is driven by factors like an aging population, the prevalence of GI diseases, technological advancements, and a shift towards minimally invasive procedures.
 

Gastrointestinal stent is a medical device intended to provide structural support and maintain the patency of the gastrointestinal tract including the esophagus, stomach, small intestine, and large intestine. These stents are used to treat various conditions that can lead to narrowing or blockages within the digestive system.
 

However, complications associated with gastrointestinal procedures is anticipated to restrict the gastrointestinal stents market expansion. Gastrointestinal procedures, including the placement of stents, can carry risks and potential complications. Risk associated with stent migration from its intended position after placement can lead to ineffective treatment. In some cases, the tissue around the stent may grow excessively, causing narrowing or even blockage of the stent. Moreover, complications can raise patient safety concerns, leading to decreased patient and physician confidence in using stents as a treatment option. This may lead to adoption of alternative treatment options leading to reduced usage of stents overall. Patients may become more reluctant to undergo stent placement thereby leading decreased patient demand for stent interventions.
 

COVID-19 Impact

The recent outbreak of COVID-19 had a negative impact that influenced the gastrointestinal stents market revenue, specifically during the initial phase of 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during the pandemic phase. Several hospitals and healthcare facilities globally experienced a significant decline in patient visits for diagnosis and treatment of gastrointestinal ailments and surgical procedures.
 

The COVID-19 pandemic reduced visits to healthcare facilities, causing medical services in several countries to be delayed, including gastrointestinal, biliary disease, colorectal cancer among others. Many hospitals and healthcare facilities were forced to postpone or cancel elective procedures, including gastrointestinal stent placements, to prioritize COVID-19 patients and conserve medical resources. This led to a substantial decline in the number of stent procedures performed, resulting in reduced market demand.
 

During the pandemic, patients were hesitant to visit hospitals or clinics for non-urgent medical issues due to fears of exposure to the virus. Routine screenings, early detection, and timely interventions for gastrointestinal conditions like cancer were postponed or missed, leading to fewer cases where stents would have been indicated. The pandemic disrupted global supply chains, affecting the production and distribution of medical devices, including gastrointestinal stents. This led to shortages, delayed shipments, and increased costs for manufacturers, limiting their ability to meet market demand.
 

Gastrointestinal Stents Market Trends

Increasing prevalence of gastrointestinal cancer is anticipated to drive the market expansion. Gastrointestinal cancers, including esophageal, gastric, and colorectal cancers, are among the most common types of cancer worldwide. For instance, according to the European Commission data in 2020, around 341,391 new cases of colorectal cancer were witnessed in the Europe. The growing incidence of these cancers contributes to a larger patient pool requiring interventions such as stent placement to address complications like obstructions and strictures. In advanced stages of gastrointestinal cancer, patients experience symptoms like difficulty swallowing, pain, and obstruction. Gastrointestinal stents are used as part of palliative care to provide relief, improve quality of life, and maintain proper digestive function, which in turn drives demand for these devices.
 

Advancements in screening techniques and increased awareness of early detection have led to more cases of gastrointestinal cancer being diagnosed at earlier stages. Gastrointestinal stent placement is often performed using minimally invasive techniques such as endoscopy. This approach appeals to both patients and healthcare providers as it reduces patient trauma, shortens hospital stays, and accelerates recovery compared to traditional surgical options. The increasing prevalence of gastrointestinal cancer creates a significant demand for interventions that can address associated complications. Gastrointestinal stents provide an effective and minimally invasive solution, making them a crucial component of cancer care.
 

Gastrointestinal Stents Market Analysis

Based on product, the gastrointestinal stents market is segmented as biliary stent, esophageal stent, colonic stent, pancreatic stent, and duodenal stent. The biliary stent dominated the market accounting over 38% business share in 2022. Biliary stents are medical devices used to treat various conditions affecting the biliary system, that include the bile ducts and gallbladder. Biliary stents are primarily used to relieve obstructions in the bile ducts. Patients with biliary obstructions often experience symptoms such as jaundice, pain, nausea, and vomiting. Biliary stents provide rapid relief from these symptoms by restoring the normal flow of bile and reducing pressure on the biliary system. Biliary stents play a critical role in improving patient outcomes by swiftly alleviating symptoms, preventing complications, and enhancing overall quality of life.
 

The ability of biliary stents to provide palliative care for patients with advanced biliary cancers significantly enhances the life expectance among patients. Biliary stents act as an essential component for comprehensive cancer care, fostering market growth. Advances in stent technology have led to the development of highly customizable biliary stents that can better fit patients' with specific anatomies and conditions.
 

Based on application, the gastrointestinal stents market is segmented as gastrointestinal cancer, biliary disease, colorectal cancer, stomach cancer and others. The biliary disease segment held a dominant market share and accounted for around USD 143.3 million in 2022. As the prevalence of biliary diseases such as gallstones, biliary strictures, and other obstructions increases, the number of patients requiring interventions like gastrointestinal stent placement also rises. Biliary diseases often require timely interventions to prevent complications and alleviate symptoms. Gastrointestinal stents serve as effective tools to manage biliary obstructions and maintain normal bile flow. Many biliary diseases can be managed effectively using minimally invasive procedures like biliary stent placement that helps to reduce trauma and helps in faster recovery.
 

As patients and healthcare providers become more informed, the demand for effective solutions like gastrointestinal stents is expected to grow at a significant pace. The aging population is more susceptible to various health conditions, including biliary diseases. As the global demographic shifts towards an older age group, the demand for interventions like stent placement to manage biliary issues is likely to increase. Hence, owing to several benefits offered by gastrointestinal stents in the diagnosis and treatment of biliary disease, the market is anticipated to witness a lucrative growth.
 

Based on material, the gastrointestinal stents market is segmented as self-expanding metal stents, plastic stents and other. The self-expanding metal stents segment accounting for around 45% market share in 2022. Self-expanding stents are designed to expand on their own once deployed, eliminating the need for manual inflation using a balloon. This simplifies the deployment process and reduces the risk of overexpansion or under expansion. Self-expanding stents are engineered to accurately conform to the shape and size of the target area within the gastrointestinal tract. This precise placement ensures optimal coverage of the obstruction or stricture. These stents are flexible and can adapt to the natural curves and contours of the gastrointestinal tract. This adaptability reduces the risk of stent migration and discomfort for the patient.
 

Self-expanding stents provide immediate relief by quickly restoring the patency of the gastrointestinal tract. Patients experience rapid alleviation of symptoms such as pain, vomiting, or difficulty swallowing. These stents are designed to maintain their expanded shape over time, providing effective and lasting relief from obstructions or strictures. Long-term patency helps avoid the need for frequent stent replacements. These benefits contribute to their effectiveness in managing obstructions, strictures, and other conditions within the gastrointestinal tract, making them a valuable tool in minimally invasive medical interventions.

Based on end-use, the gastrointestinal stents market is segmented as hospitals, ambulatory surgical centers and others. The hospitals segment exceeded USD 224.1 million in 2022. Hospitals are equipped with advanced diagnostic and interventional equipment, facilitating precise diagnosis, treatment planning, and stent placement procedures. Complex gastrointestinal cases, such as severe obstructions or strictures require specialized medical expertise available in hospital settings. Patients prefer inpatient admission to ensure comprehensive care from multidisciplinary teams. Hospitals offer a comprehensive range of medical services and specialties under one roof. Patients seeking treatment for gastrointestinal conditions, including stent placement, are more likely to choose hospitals due to the availability of various medical experts and resources. Gastrointestinal stent placement often requires the involvement of gastroenterologists, interventional radiologists, and surgeons.
 

Hospitals provide access to a multidisciplinary team of specialists, ensuring optimal care and successful stent procedures. Hospitals are equipped with state-of-the-art diagnostic and interventional equipment necessary for precise diagnosis, treatment planning, and stent placement. Hospitals provide continuous monitoring and comprehensive post-operative care, which is crucial for patients undergoing procedures like stent placement. Thus, availability and accessibility to advanced diagnosis and treatment incorporating gastrointestinal stents coupled with the rising prevalence of chronic ailments will surge patient visits to hospitals, thereby propelling the segment revenue.
 

North America gastrointestinal stents market was valued at USD 169.9 million in 2022. This high market share is ascribed to a variety of factors, including the presence of significant industry players, an increase in the number of patients suffering from gastrointestinal disorders, an expanding elderly population, among others. Gastrointestinal disorders, including obstructions, strictures, and other conditions that require stent placement, are prevalent in North America. The region's aging population and changing lifestyle patterns contribute to the growing incidence of such conditions. Gastrointestinal stents aid in the diagnosis and treatment of these chronic conditions thereby augmenting the market trends.
 

Increased awareness campaigns and healthcare education efforts in North America have led to early detection and intervention for gastrointestinal conditions. Early intervention often involves procedures like stent placement, thereby boosting market demand. North America boasts advanced healthcare infrastructure, including well-equipped hospitals, specialized medical centers, and state-of-the-art medical technology. This infrastructure supports the demand for gastrointestinal stents and their effective deployment. North America's relatively high healthcare spending and comprehensive insurance coverage make gastrointestinal stent procedures accessible to a larger portion of the population, further driving product demand.
 

Gastrointestinal Stents Market Share

Some of the major players operating in the gastrointestinal stents market are Becton Dickinson and Company,:

• Boston Scientific Corporation
• Cantel Medical
•  Conmed Corporation
•  Cook Medical
• ELLA-CS, s.r.o.
•  Gore Medical
•  Hobbs Medical
•  Medtronic plc,
• Micro-Tech (Nanjing) Co
• Olympus America 

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
 

Gastrointestinal Stents Industry Leaders:

• In February 2023, Olympus Corporation announced the acquisition of Taewoong Medical Co., Ltd, a manufacturer of medical devices including gastrointestinal (GI) metallic stents among others. This acquisition helped the company to expand their GI EndoTherapy product portfolio, enhance their R&D capabilities and increase the business revenue.
   
• In June 2022, Boston Scientific Corporation announced a strategic agreement with Synergy Innovation Co., Ltd to acquire a majority shares of M.I.Tech Co., Ltd. This company is a manufacturer of HANAROSTENT technology, providing conformable, non-vascular, self-expanding metal stents. This strategic move helped the company to integrate advance technologies in their business, enhance their customer base and gain a competitive edge over its peers.
   

Gastrointestinal stents market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product, 2018 - 2032 (USD Million)

• Biliary stent
• Esophageal stent
• Colonic stent
• Pancreatic stent
• Duodenal stent

By Application, 2018 - 2032 (USD Million)

• Gastrointestinal Cancer
• Biliary Disease
• Colorectal Cancer
• Stomach Cancer
• Others

By Material, 2018 - 2032 (USD Million)

• Self-expanding metal stents
• Plastic Stents
• Other

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE